BMX
Drug: QL-XII-47
Cancer code: LAML
Cancer type: acute_myeloid_leukaemia
Drug treatment table
| Cell line ID |
Cell line name |
Mutation in substructure |
IC50(uM) |
| SIDM00785 | KG-1 | achelix (464) | 5.7441 |
| SIDM00437 | MOLM-13 | None | 0.5039 |
| SIDM00461 | OCI-AML5 | None | 0.5928 |
| SIDM00458 | OCI-M1 | None | 0.6538 |
| SIDM00450 | PL-21 | None | 1.4306 |
| SIDM00951 | CTV-1 | None | 0.6805 |
| SIDM00829 | HL-60 | None | 3.3815 |
| SIDM01057 | GDM-1 | None | 0.4371 |
| SIDM00594 | HEL | None | 0.3463 |
| SIDM01005 | KASUMI-1 | None | 0.4828 |
| SIDM01019 | KMOE-2 | None | 2.2964 |
| SIDM00441 | ML-2 | None | 0.7422 |
| SIDM01023 | MONO-MAC-6 | None | 1.2321 |
| SIDM00576 | NKM-1 | None | 0.4978 |
| SIDM00580 | NOMO-1 | None | 0.9359 |
| SIDM00363 | P31-FUJ | None | 9.7932 |
| SIDM00396 | SIG-M5 | None | 0.1999 |
| SIDM01172 | THP-1 | None | 0.8644 |
| SIDM00467 | QIMR-WIL | None | 0.3009 |
| SIDM00959 | CMK | None | 0.4105 |
| SIDM00917 | CESS | None | 0.5965 |
| SIDM00446 | OCI-AML2 | None | 4.5892 |
| SIDM00462 | OCI-AML3 | None | 0.6605 |
| SIDM00428 | NB4 | None | 1.2266 |
| SIDM00338 | ME-1 | None | 7.0503 |
